|
1
|
Nagini S: Carcinoma of the stomach: A
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
PDQ Screening and Prevention Editorial
Board: Stomach (Gastric) Cancer Prevention (PDQ®): Health
Professional Version, . PDQ Cancer Information Summaries. National
Cancer Institute (US); Bethesda (MD): 2002
|
|
3
|
Li J, Zhang S, Liu J, Shao M and Chen L:
Review of clinical investigation on recurrence of gastric cancer
following curative resection. Chin Med J. 125:1479–1495.
2012.PubMed/NCBI
|
|
4
|
Roukos DH and Kappas AM: Limitations in
controlling risk for recurrence after curative surgery for advanced
gastric cancer are now well-explained by molecular-based
mechanisms. Ann Surg Oncol. 8:620–621. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang R and Su B: Small but influential:
The role of microRNAs on gene regulatory network and 3′UTR
evolution. J Genet Genomics. 36:1–6. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143(35–47): e22012.
|
|
9
|
Mizuno K, Seki N, Mataki H, Matsushita R,
Kamikawaji K, Kumamoto T, Takagi K, Goto Y, Nishikawa R, Kato M, et
al: Tumor-suppressive microRNA-29 family inhibits cancer cell
migration and invasion directly targeting LOXL2 in lung squamous
cell carcinoma. Int J Oncol. 48:450–460. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song S and Ajani JA: The role of microRNAs
in cancers of the upper gastrointestinal tract. Nat Rev
Gastroenterol Hepatol. 10:109–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung CC and Chanock SJ: Current status of
genome-wide association studies in cancer. Hum Genet. 130:59–78.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng H, Song F, Zhang L, Yang D, Ji P,
Wang Y, Almeida M, Calin GA, Hao X, Wei Q, et al: Genetic variants
at the miR-124 binding site on the cytoskeleton-organizing IQGAP1
gene confer differential predisposition to breast cancer. Int J
Oncol. 38:1153–1161. 2011.PubMed/NCBI
|
|
13
|
Saunders MA, Liang H and Li WH: Human
polymorphism at microRNAs and microRNA target sites. Proc Natl Acad
Sci USA. 104:pp. 3300–3305. 2007, View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang XW, Shen GZ, Cao LQ, Jiang XF, Peng
HP, Shen G, Chen D and Xue P: MicroRNA-1269 promotes proliferation
in human hepatocellular carcinoma via downregulation of FOXO1. BMC
Cancer. 14:9092014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bu P, Wang L, Chen KY, Rakhilin N, Sun J,
Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, et al: miR-1269
promotes metastasis and forms a positive feedback loop with TGF-β.
Nat Commun. 6:68792015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Persson H, Kvist A, Rego N, Staaf J,
Vallon-Christersson J, Luts L, Loman N, Jonsson G, Naya H, Hoglund
M, et al: Identification of new microRNAs in paired normal and
tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
Cancer Res. 71:78–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma Y, Wang R, Zhang J, Li W, Gao C, Liu J
and Wang J: Identification of miR-423 and miR-499 polymorphisms on
affecting the risk of hepatocellular carcinoma in a large-scale
population. Genet Test Mol Biomarkers. 18:516–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dupuy D, Bertin N, Hidalgo CA, Venkatesan
K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, et al:
Genome-scale analysis of in vivo spatiotemporal promoter activity
in Caenorhabditis elegans. Nat Biotechnol. 25:663–668. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32:D277–D280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi M, Horton JD, Cohen JC, Hobbs HH and
Stephens RM: WholePathwayScope: A comprehensive pathway-based
analysis tool for high-throughput data. BMC Bioinformatics.
7:302006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie L, Shen Y, Franke D, Sebastian V,
Bawendi MG and Jensen KF: Characterization of indium phosphide
quantum dot growth intermediates using MALDI-TOF mass spectrometry.
J Am Chem Soc. 2016. View Article : Google Scholar
|
|
24
|
Wang Y, Tang N, Hui T, Wang S, Zeng X, Li
H and Ma J: Identification of endogenous reference genes for
RT-qPCR analysis of plasma microRNAs levels in rats with
acetaminophen-induced hepatotoxicity. J Appl Toxicol. 33:1330–1336.
2013.PubMed/NCBI
|
|
25
|
Zhang X, Nie Y, Du Y, Cao J, Shen B and Li
Y: MicroRNA-181a promotes gastric cancer by negatively regulating
tumor suppressor KLF6. Tumour Biol. 33:1589–1597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Lv C, Jin H, Xu M, Kang M, Chu H,
Tong N, Wu D, Zhu H, Gong W, et al: A common genetic variation in
the promoter of miR-107 is associated with gastric adenocarcinoma
susceptibility and survival. Mutat Res. 769:35–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu B, Song P, Lu M, Wang B and Zhao Q: The
association between miR-146a gene rs2910164 polymorphism and
gastric cancer risk: A meta-analysis. Biomed Pharmacother.
68:923–928. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai M, Zhang Y, Ma Y, Li W, Min P, Qiu J,
Xu W, Zhang M, Li M, Li L, et al: Association between microRNA-499
polymorphism and gastric cancer risk in Chinese population. Bull
Cancer. 102:973–978. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Laity JH, Lee BM and Wright PE: Zinc
finger proteins: New insights into structural and functional
diversity. Curr Opin Struct Biol. 11:39–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cohen PA, Donini CF, Nguyen NT, Lincet H
and Vendrell JA: The dark side of ZNF217, a key regulator of
tumorigenesis with powerful biomarker value. Oncotarget.
6:41566–41581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ravasi T, Suzuki H, Cannistraci CV,
Katayama S, Bajic VB, Tan K, Akalin A, Schmeier S,
Kanamori-Katayama M, Bertin N, et al: An atlas of combinatorial
transcriptional regulation in mouse and man. Cell. 140:744–752.
2010. View Article : Google Scholar : PubMed/NCBI
|
